Heptares Therapeutics, the leading GPCR drug discovery and development company, announces the publication of a scientific article describing the high resolution X-ray crystal structure of the corticotropin-releasing factor receptor 1 (CRF1) receptor. The paper has been published in Nature and is...
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, have announced the publication of results from the Phase II EAGLE clinical trial for BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia, showing that BL-1020...
Patients at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare were the first in the nation to participate in a clinical trial to determine the safety, tolerability and effectiveness for usage of a new drug combination consisting of a standard drug called gemcitabine and a...
Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company's lead drug candidate NV-143, that...
A group of UK primary school children have achieved a world first by having their school science project accepted for publication in an internationally recognised peer-reviewed Royal Society journal. The paper, which reports novel findings in how bumblebees perceive colour, is published in...
Bionovo, Inc. (Nasdaq: BNVI) announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth. These results provide evidence that drugs that stimulate the production of or activate ERb are...
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of...
human-interest pieces/profiles? I have to think of a name for a mock-newspaper for my class. Any suggestions? The pieces included will consist of journalistic stories/profiles in the form of human-interest pieces.
I'm looking for something that doesn't have the word "profile" in it.
Hello! I'm 13 years old, (14 in June) so this won't be too spectacular. I'm including quite a bit of it, so hopefully anyone who likes to read could give me some constructive critism? :)
Here it is:
July 2, 1990: HANNAH
Down here at the beach, the air holds the scent of fresh sea salt all...
...Jhumpa Lahiri? I have the original publication date, and the publisher, but I need to find information about the number of copies published, and how many re-printings there have been.
I'm also looking for information about the book's "critical standing in American literary history" so, any...
Commenting on the publication of the NHS Scotland Chief Executive's annual report on FridayDr Brian Keighley, Chairman of the BMA in Scotland, said: "I would like to thank Dr Kevin Woods for his appreciation of the hard work and dedication of NHS staff. Without a dedicated and highly skilled...
“All liars and murderers are religionists. Whenever a murderer is about to be executed, he has some religious practitioner say some senseless words over him, which is supposed to save him but which does no good. The Devil was the originator of Religion, and the Devil is the father of lies and ‘a...
Hey all, I'm launching a free publication in February and I was wondering if I could use the internet as the main source. Will I get sued if I publish any articles off the net?